1. Home
  2. HAFN vs LGND Comparison

HAFN vs LGND Comparison

Compare HAFN & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hafnia Limited

HAFN

Hafnia Limited

N/A

Current Price

$10.69

Market Cap

3.7B

Sector

N/A

ML Signal

N/A

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

N/A

Current Price

$302.40

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HAFN
LGND
Founded
2012
1987
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
HAFN
LGND
Price
$10.69
$302.40
Analyst Decision
Buy
Strong Buy
Analyst Count
2
11
Target Price
$11.50
★ $344.25
AVG Volume (30 Days)
★ 2.9M
210.4K
Earning Date
08-28-2026
11-05-2026
Dividend Yield
★ 10.24%
N/A
EPS Growth
N/A
★ 2886.36
EPS
N/A
★ 1.63
Revenue
N/A
★ $141,102,000.00
Revenue This Year
N/A
$8.04
Revenue Next Year
N/A
$31.71
P/E Ratio
★ $11.39
$180.98
Revenue Growth
N/A
★ 29.48
52 Week Low
$5.17
$175.89
52 Week High
$10.90
$326.63

Technical Indicators

Market Signals
Indicator
HAFN
LGND
Relative Strength Index (RSI) 69.41 56.38
Support Level $8.45 $276.71
Resistance Level N/A $320.45
Average True Range (ATR) 0.30 10.72
MACD 0.07 -0.43
Stochastic Oscillator 91.55 63.07

Price Performance

Historical Comparison
HAFN
LGND

About HAFN Hafnia Limited

Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk. Company manages it's business through the following reporting segments: LR2 tankers, LR1 tankers, MR tankers, Handy tankers.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: